Should You Buy Immunitybio Inc (IBRX) Stock on Monday?

Immunitybio Inc (IBRX) stock has risen 1.93% over the past week and gets a Neutral rating from InvestorsObserver Sentiment Indicator.

Immunitybio Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on IBRX!

See Full IBRX Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With IBRX Stock Today?

Immunitybio Inc (IBRX) stock has gained 2.43% while the S&P 500 is down -0.18% as of 11:11 AM on Monday, Nov 27. IBRX is higher by $0.10 from the previous closing price of $4.12 on volume of 1,508,924 shares. Over the past year the S&P 500 has risen 14.81% while IBRX is down -16.10%. IBRX lost -$1.05 per share in the over the last 12 months.

More About Immunitybio Inc

ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate (natural killer cell and macrophage) and adaptive (T cell) immune systems to create long-term immunological memory. Click Here to get the full Stock Report for Immunitybio Inc stock.